8 results match your criteria: "Institute of Research on Cancer and Aging in Nice[Affiliation]"

Sunitinib is an oral tyrosine kinase inhibitor used in treating advanced renal cell carcinoma (RCC) that exhibits significant efficacy but faces resistance in 30% of patients. Identifying the molecular mechanisms underlying resistance could enable the development of strategies to enhance sunitinib sensitivity. Here, we showed that sunitinib induces a metabolic shift leading to increased serine synthesis in RCC cells.

View Article and Find Full Text PDF

Need for a Dedicated Ophthalmic Malignancy Clinico-Biological Biobank: The Nice Ocular MAlignancy (NOMA) Biobank.

Cancers (Basel)

April 2023

Institute of Research on Cancer and Aging in Nice (IRCAN), Team 4, Centre Antoine Lacassagne, Centre National de la Recherche Scientifique (CNRS), Institut National de la Santé et de la Recherche Médicale (INSERM), Fédération Hospitalo-Universitaire (FHU) OncoAge, Côte d'Azur University, 06189 Nice, France.

Article Synopsis
  • Ophthalmic malignancies, including uveal melanoma (UM), are rare tumors affecting the eye and surrounding areas, marked by their diverse characteristics and low incidence rates.
  • Uveal melanoma is particularly challenging due to its rarity, risks associated with tissue biopsy, and high likelihood of aggressive metastatic spread, affecting patient outcomes.
  • The creation of a dedicated UM biobank aims to collect valuable tumor samples for research, helping to uncover the disease's pathogenesis and leading to potential early detection and treatment strategies.
View Article and Find Full Text PDF

Host genetic variability and determinants of severe COVID-19.

Trends Genet

March 2023

Centre Antoine Lacassagne, Service de Valorisation Scientifique, F-06100 Nice, France. Electronic address:

Since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak, convergent studies have provided evidence that host genetic background may contribute to the development of severe coronavirus disease (COVID-19). Here, we summarize how some genetic variations, such as in SARS-CoV-2 receptor angiotensin-converting enzyme 2 or interferon signaling pathway, may help to understand why some individuals can develop severe COVID-19.

View Article and Find Full Text PDF

The LEGO® brick road to open science and biotechnology.

Trends Biotechnol

September 2022

Université Côte d'Azur, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Institute of Research on Cancer and Aging in Nice (IRCAN), 28 Avenue de Valombrose, 06107 Nice CEDEX 2, France. Electronic address:

LEGO® is a brand of toys that have entertained generations of children. Beyond amusement, LEGO® bricks also constitute a building ecosystem of their own that creators from the general public, as well as scientists and engineers, can use to design and assemble devices for all purposes, including scientific research and biotechnology. We describe several of these constructions to highlight the construction properties of LEGO® and their advantages, caveats, and impact in biotechnology.

View Article and Find Full Text PDF

The Carcinogen Cadmium Activates Lysine 63 (K63)-Linked Ubiquitin-Dependent Signaling and Inhibits Selective Autophagy.

Cancers (Basel)

May 2021

Université Côte d'Azur, Institute of Research on Cancer and Aging in Nice (IRCAN), Centre National de la Recherche Scientifique (CNRS), Institut National de la Santé et de la Recherche Médicale (INSERM), Fédération Hospitalo-Universitaire (FHU) OncoAge, Centre Antoine Lacassagne, F-06189 Nice, France.

Signaling, proliferation, and inflammation are dependent on K63-linked ubiquitination-conjugation of a chain of ubiquitin molecules linked via lysine 63. However, very little information is currently available about how K63-linked ubiquitination is subverted in cancer. The present study provides, for the first time, evidence that cadmium (Cd), a widespread environmental carcinogen, is a potent activator of K63-linked ubiquitination, independently of oxidative damage, activation of ubiquitin ligase, or proteasome impairment.

View Article and Find Full Text PDF

Using Genetics To Dissect SARS-CoV-2 Infection.

Trends Genet

March 2021

Université Côte d'Azur, Centre Antoine Lacassagne, Unité Propre de Recherche 7497 Université Côte d'Azur, F-06100 Nice, France. Electronic address:

To uncover the key cellular pathways associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity, Daniloski and coworkers used CRISPR-based whole-genome screening. Their results could propose new or repositioned drugs for the ongoing fight against COVID-19.

View Article and Find Full Text PDF
Article Synopsis
  • Genome amplification in soft tissue tumors often results in the formation of complex structures called rings or giant rod-shaped marker chromosomes, which are stabilized by neocentromeres that help cancer progress.
  • Research on well-differentiated liposarcoma and lung sarcomatoid carcinoma shows that these neocentromeres form intricate patchworks of short amplified sequences, indicating a high level of genetic complexity and adaptive changes during tumor progression.
  • The expansion of neocentromeric domains and unusual centromere behaviors contribute to the instability of these genetic structures, while increased fusion transcripts and oncogene expression may drive genomic amplification and cancer development.
View Article and Find Full Text PDF

Nonsuppressed Glucagon After Glucose Challenge as a Potential Predictor for Glucose Tolerance.

Diabetes

May 2017

Division of Endocrinology, Diabetology, Nephrology, Vascular Disease, and Clinical Chemistry, Department of Internal Medicine, University Hospital, Eberhard Karls University Tübingen, Tübingen, Germany

Article Synopsis
  • The study explored how glucagon levels respond after a glucose challenge during oral glucose tolerance tests (OGTTs) in individuals without diabetes.
  • It found that while 66-79% of participants suppressed glucagon levels, 21-34% had increased glucagon, and those with nonsuppressed levels surprisingly had a lower risk of impaired glucose tolerance (IGT).
  • The findings suggest that lower glucagon suppression may indicate a healthier metabolic state rather than being detrimental, as these individuals also had better insulin sensitivity and lower liver fat.
View Article and Find Full Text PDF